This is the case for the neuroblastoma tumors in our UMAP analysis (cluster 2h, Figure 6H), which are characterized by lower LMO1 but high LMO3 expression levels (Figure 6, F and H). The gene discussed is LMO3; the disease is neuroblastoma.